SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00033



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00033_20160513_TIL1 2 Human HLA-A02:01,HLA-B18:01,HLA-B38:01,HLA-C05:01
SYSMHC00033_20160513_TIL2 2 Human no allele
SYSMHC00033_20160513_TIL3 2 Human HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02
SYSMHC00033_20160513_TIL4 2 Human no allele
SYSMHC00033_20160517_DC 5 Human no allele
SYSMHC00033_20160517_GD149 5 Human HLA-A01:01,HLA-A24:02,HLA-B38:01,HLA-B44:03,HLA-C06:02,HLA-C12:03
SYSMHC00033_Apher-1 2 Human HLA-A03:01,HLA-A29:02,HLA-B44:02,HLA-B44:03,HLA-C12:03,HLA-C16:01
SYSMHC00033_Apher-6 2 Human HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02
SYSMHC00033_CM647_MG 2 Human HLA-A01:01,HLA-A24:02,HLA-B13:02,HLA-B39:06,HLA-C06:02,HLA-C12:03
SYSMHC00033_CM647_NG 2 Human HLA-A01:01,HLA-A24:02,HLA-B13:02,HLA-B39:06,HLA-C06:02,HLA-C12:03
SYSMHC00033_HLApI_TIL3 3 Human HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02
SYSMHC00033_HLApI_pooledTIL3 3 Human HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02
SYSMHC00033_MD155 3 Human HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B18:01,HLA-C03:03,HLA-C07:01
SYSMHC00033_PD42 2 Human HLA-A02:06,HLA-A24:02,HLA-B07:02,HLA-B55:01,HLA-C01:02,HLA-C07:02
SYSMHC00033_RA957_MG 2 Human HLA-A02:20,HLA-A68:01,HLA-B35:03,HLA-B39:01,HLA-C04:01,HLA-C07:02
SYSMHC00033_RA957_NG 2 Human HLA-A02:20,HLA-A68:01,HLA-B35:03,HLA-B39:01,HLA-C04:01,HLA-C07:02



Detailed view of sample SYSMHC00033_HLApI_TIL3



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00033 SYSMHC00033_HLApI_TIL3 20160902_QEh1_LC2_CHC_SA_HLApI_TIL3_1.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 28832583 native Immunoaffinity W6/32 Q-Exactive HF nanoflow UHPLC Easy nLC 1211 no DDA HCD 1
SYSMHC00033 SYSMHC00033_HLApI_TIL3 20160902_QEh1_LC2_CHC_SA_HLApI_TIL3_2.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 28832583 native Immunoaffinity W6/32 Q-Exactive HF nanoflow UHPLC Easy nLC 1212 no DDA HCD 2
SYSMHC00033 SYSMHC00033_HLApI_TIL3 20160902_QEh1_LC2_CHC_SA_HLApI_TIL3_3.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 28832583 native Immunoaffinity W6/32 Q-Exactive HF nanoflow UHPLC Easy nLC 1213 no DDA HCD 3